John Lin

10PUBLICATIONS
70CO-AUTHORS
Pricing (incl. consumer value estimation)Cancer diagnosisSocial epidemiologyTaxation accountingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 25, 2026
Identifying Meaningful Patient Savings on Generics: Direct-to-Consumer Prices Versus Commercial Insurance Cost Sharing.

|Mar 30, 2026
Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability.

Mohammad Jad Moussa, Alexander Y Andreev-Drakhlin, Aradhana M Venkatesan

|Sep 26, 2025
Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality.

Maureen E Canavan, Lee Cheng, Jenny Jing Xiang

|Sep 19, 2025
Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis.

Pengxiang Li, John K Lin, Matthew J Klebanoff

|Aug 27, 2025
Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers.

John K Lin, Jiangong Niu, Sharon H Giordano

|Aug 25, 2025
High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Yago Nieto, John F Ward, Wayne Hofstetter

Pageof 2

Frequent Collaborators

4 joint publications

Jalpa A Doshi

3 joint publications

Jenny Xiang

3 joint publications

Sharon H Giordano

2 joint publications

Rebecca A Snyder